Tag: Primary prevention

A 2024 meta-analysis found aspirin therapy for primary prevention was associated with a 47% increased risk of major bleeding compared to no aspirin. Understanding **when should aspirin be stopped for primary prevention** is therefore crucial for mitigating these significant risks, especially in light of evolving medical guidelines.

The average lifespan is increasing globally, and with it comes a growing older population facing cardiovascular disease risk. For this demographic, a key question for patients and clinicians is, "At what age is statin no longer beneficial?" The answer is not a simple number, but rather a nuanced assessment that depends on whether the medication is used for primary or secondary prevention and the patient's overall health.

Recent studies have prompted a major reversal in medical advice, with the U.S. Preventive Services Task Force (USPSTF) now recommending against starting daily low-dose aspirin for many people. This article explores why should you not take 81 mg aspirin daily without a doctor's specific recommendation.

After decades of a blanket recommendation, recent cardiovascular guidelines have significantly shifted the approach to a daily baby aspirin regimen. The decision to start or continue aspirin now depends heavily on an individual's specific risk profile, differentiating sharply between those preventing a first event and those preventing a second.

A 2019 study reported that more than half of patients eligible for statins in some populations do not receive them, often due to patient refusal or physician inaction. This highlights the complex and sometimes contentious debate around statin therapy, addressing the critical question: **Why do some doctors not like statins?**

Over 40 million Americans currently take statins to lower cholesterol and reduce the risk of heart disease [1.3.2]. Despite their widespread use, a significant debate exists within the medical community, leading many to ask: why are so many doctors against statins?

Statins are among the most prescribed medications globally, with over 40 million users in the U.S. alone [1.4.2]. Despite their proven ability to lower cholesterol, a significant debate continues over their use. This article examines the core question: **Why are some doctors against statins?**